Dyne Therapeutics Inc.
DYN | NASDAQ
$17.12
+$0.01 (+0.06%)
At close: Sep 21, 2026, 4:00 PM ET
$18.44
+$1.32 (+7.71%)
Pre-market:
Sep 22, 2026, 8:42 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -5.64 | -6.99 | -3.37 | -3.59 | -4.06 | -16.94 |
PEG Ratio | -1.90 | 0.48 | -0.15 | -0.35 | -0.03 | -0.05 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.58 | 3.52 | 8.70 | 2.39 | 1.64 | 2.90 |
P/FCF Ratio | -6.20 | -7.53 | -4.20 | -3.84 | -4.91 | -20.82 |
P/OCF Ratio | -6.23 | -7.59 | -4.22 | -3.92 | -5.06 | -21.34 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.02 | 0.04 | 0.30 | 0.12 | 0.09 | n/a |
Quick Ratio | 22.25 | 15.60 | 2.53 | 9.46 | 13.31 | 31.83 |
Current Ratio | 22.25 | 15.60 | 2.53 | 9.46 | 13.31 | 31.83 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -75.61 | n/a | n/a | -58.61 | n/a | -148.10 |
Return on Equity | -45.90% | -50.40% | -258.44% | -66.61% | -40.55% | -17.16% |
Return on Assets | -37.59% | -45.92% | -142.92% | -54.88% | -35.07% | -16.62% |
Return on Invested Capital | -41.02% | -52.60% | -204% | -60.44% | -37.43% | -16.93% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DYN